CENNA BIOSCIENCES INC
Developing Disease-Modifying Drugs for Alzheimer's Disease
San Diego, United States · Founded 2016
- Headquarters
- San Diego, California
- Founded
- 2016
- Business Model
- B2G
- Website
- cennabiosciences.com
About
Cenna Biosciences is a privately-held biopharmaceutical company based in La Jolla, California, focused on developing novel disease-modifying treatments for Alzheimer's disease. Their lead drug candidate, Nubytide, is a proprietary peptide therapy that inhibits beta amyloid (Aß) production and reduces markers of inflammation and Tau pathology. Cenna has secured multiple NIH SBIR grants including a $2.7M Phase II award from the National Institute on Aging.
Summary
CENNA BIOSCIENCES INC is a Biotech company based in San Diego, United States, founded in 2016.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/cenna-biosciences-inc"><img src="https://indexed.vc/api/badge/company/cenna-biosciences-inc" alt="CENNA BIOSCIENCES INC on Indexed.vc" width="260" height="76" /></a>